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Abstract
Introduction: The aim of the present multicenter study was to assess long term (36 months) health related quality
of life in patients after critical illness, compare ICU survivors health related quality of life to that of the general
population and examine the impact of pre-existing disease and factors related to ICU care on health related quality
of life.
Methods: Prospective, longitudinal, multicentre trial in three combined medical and surgical intensive care units of
one university and two general hospitals in Sweden. By mailed questionnaires, health related quality of life was
assessed at 6, 12, 24 and 36 months after the stay in ICU by EQ-5D and SF-36, and information of pre-existing
disease was collected at the 6 months measure. ICU related factors were obtained from the local ICU database.
Comorbidity and health related quality of life (EQ-5D; SF-36) was examined in the reference group. Among the
5306 patients admitted, 1663 were considered eligible (>24 hrs in the intensive care unit, and age ≥ 18 yrs, and
alive 6 months after discharge). At the 6 month measure 980 (59%) patients answered the questionnaire. Of these
739 (75%) also answered at 12 month, 595 (61%) at 24 month, and 478 (47%) answered at the 36 month measure.
As reference group, a random sample (n = 6093) of people from the uptake area of the hospitals were used in
which concurrent disease was assessed and adjusted for.
Results: Only small improvements were recorded in health related quality of life up to 36 months after ICU
admission. The majority of the reduction in health related quality of life after care in the ICU was related to the
health related quality of life effects of pre-existing diseases. No significant effect on the long-term health related
quality of life by any of the ICU-related factors was discernible.
Conclusions: A large proportion of the reduction in the health related quality of life after being in the ICU is
attributable to pre-existing disease. The importance of the effect of pre-existing disease is further supported by the
small, long term increment in the health related quality of life after treatment in the ICU. The reliability of the
conclusions is supported by the size of the study populations and the long follow-up period.
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There is increasing focus on Health-Related Quality of
Life (HRQoL) after critical illness [1]. In a recent sys-
tematic review of relevant factors for the outcome of
H R Q o L ,a f t e rc a r ei na nI C U ,i tw a sf o u n dt h a ti m p o r -
tant predictors other than age and sex are severity of ill-
ness (Acute Physiology and Chronic health Evaluation
(APACHE) score), admission (acute/elective), or length
of stay (LoS) [2]. In the same review, it was also sug-
gested that pre-existing impairment or disease may be
important because they are known to affect HRQoL and
therefore should be controlled for. It will not be possible
to accurately estimate the HRQoL of ICU survivors, the
impact on HRQoL among ICU survivors or to compare
the HRQoL of ICU survivors with that of the general
population unless pre-existing disease is accounted for
[3-7]. Interestingly, few studies have adjusted for the
effect of the pre-existing diseases.
We used a new technique, based on a control popula-
tion adjusted for pre-existing diseases from the uptake
area of the study hospitals in this prospective, multicen-
tre study with 36 months of follow up. HRQoL was
examined after care in the ICU to assess the importance
of pre-existing disease. The effect on HRQoL has been
examined further in conjunction with the factors pre-
viously thought to be important, such as age, sex, social
factors, admission diagnosis, APACHE II score, LoS in
ICU and in hospital, and time spent on a ventilator.
Given the nature of HRQoL instruments, we hypothe-
sised (in line with our findings in our previous pilot
study [5]) that pre-existing disease is the most important
factor and that other factors related to intensive care
such as APACHE II score, admission diagnosis, time on
ventilator, and in ICU and duration of stay are of less
importance.
In accordance with our pre-study hypothesis our main
findings were: firstly, only a small improvement in
HRQoL over time, up to 36 months post ICU was seen;
secondly, ICU-related factors had little effect on the
reported HRQoL; and, lastly, the overall most important
factor for the decreased HRQoL reported by the patients
in the long term was their pre-existing diseases.
Materials and methods
Design
This prospective, longitudinal multicentre study took
place in three mixed medical-surgical ICUs in the south-
east of Sweden: one university and two general hospitals.
Patients with primary coronary disease, those recovering
after heart surgery and neurosurgery, neonates or
patients with burns are treated in other specialised units
and were excluded. The ICUs each admit 500 to 750
patients annually. Nearly all the admissions to these
three ICUs are emergencies and the most common
primary diagnoses are multiple trauma, sepsis, and dis-
turbances in respiratory or circulatory systems or both.
Study population and reference group
All patients aged 18 years and older, who were admitted
consecutively between 1 August 2000 and 30 June 2004,
remained in the ICU for more than 24 hours, were alive
six months after discharge from hospital and consented
to participate in the study were included.
Patients who were readmitted were included only on
their first admission. After the national Swedish Social
Security register had been checked to avoid sending
enquiries to patients who had died, we sent information
and a request to participate to each patient by mail,
together with a structured questionnaire and a pread-
dressed and prepaid return envelope. Patients who had
not responded within 10 days were contacted by tele-
phone by one of the investigators (LO, ES or CB). If the
telephone contact or first mailing achieved no answer
two reminders were sent out (at three and six weeks).
The patients gave their informed consent prior to parti-
cipating in the study.
Data from a public health survey of the county of
Östergötland were used for comparison of HRQoL and
pre-existing disease. This reference group consisted of a
random sample of the general population living in the
uptake area of the hospitals. That survey was
approached for the purpose of monitoring the general
health of the reference group population in a different
study and was completed during 1999 [8]. Question-
naires were initially sent out to 10,000 people aged 20
to 74 years. After two reminders, 6093 (61%) had
responded [8].
The clinical databases in each hospital were used to
extract data on age, sex, admission diagnosis, APACHE
II score, LoS in ICU and hospital, time spent on the
ventilator and outcome. The patients were categorised
into diagnostic categories according to the main reason
for admission: multiple trauma, sepsis, gastrointestinal,
respiratory and other.
The study was approved by the Committee for Ethical
Research at the University of Health in Linköping.
Questionnaires and instruments
A set of structured questionnaires were mailed to the
study population at 6, 12, 24 and 36 months after
d i s c h a r g ef r o mh o s p i t a l .T h eq u e s t i o n n a i r ec o n t a i n e d
questions about the patients’ background (employment,
listed sick or not, born in Sweden or not, and pre-exist-
ing disease self-reported diagnosis). The questionnaire
also asked, ‘Have you had any significant illness, reduced
body function or other medical problem and have had it
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Page 2 of 10for more than six months prior to the ICU period?’ with
the answer options of ‘yes’ or ‘no’. Further, this question
also had the pre-specified illnesses alternatives: ‘cancer,
diabetes, heart failure, asthma/allergy, rheumatic-gastro-
intestinal, blood, kidney, psychiatric, neurological
disease, thyroid or any other metabolic disturbance, or
any other long-term illness’. The last alternative was an
open question with a slot for free text.
The instruments chosen for the evaluation of HRQoL
were EuroQol 5-Dimensions (EQ-5D) questionnaire
[9,10] and medical outcome Short Form health survey
(SF-36) [11,12]. Both are known internationally and
have been recommended for measuring HRQoL in criti-
cal care [1] although EQ-5D has not been validated in
the ICU population. The EQ-5D is developed and
applied by an international multidisciplinary research
group from seven Scandinavian countries. The instru-
ment is therefore validated in a Swedish population [13].
The EQ-5D involves a health state classification scheme
of five items (mobility, self-care, usual activities, pain/
discomfort and anxiety/depression), each having three
alternatives (1 = no problems, 2 = moderate problems,
and 3 = severe problems). The combination of answers
on the five items represents the health state, ranging
from 0 (worst possible health state) to 1.0 (best possible
health).
SF-36 has reliability and validity in the ICU population
[12,14]. It has been translated into Swedish and vali-
dated in a representative sample of the population
[11,15]. It has 36 questions and generates a health pro-
file of eight sub-scale scores: physical functioning, role
limitations due to physical problems, bodily pain, gen-
eral health, vitality, social functioning, role limitations
due to emotional problems and mental health [15]. The
scores on all sub-scales are transformed to a scale from
0 (the worst score) to 100 (best score) [16].
The questionnaire to the reference group also
included questions on background characteristics as
above, and questions about HRQoL ((EQ-5D and Medi-
cal outcome Short-Form health survey (SF-36)question-
naire) and health problems. Details and the method for
this part has been previously discussed [5] .
Statistical analysis
Data are presented as mean, median and 95% confi-
dence intervals (CI). Unadjusted two-sample compari-
sons (Pearson’sc h is q u a r e da n dS t u d e n t ’stt e s t )w e r e
used to assess differences in background characteristics
between the groups as appropriate. In the comparison
of HRQoL (EQ-5D and SF-36) between the reference
group and the study group at different occasions (6, 12,
24 and 36 months) a t-test (mean) and Wilcoxon (med-
ian) was used. A general linear model (GLM) was used
to analyse the impact of background and ICU-related
factors on HRQoL. Marginal means were estimated
from the model including all statistically significant
(P < 0.050) variables. To maximise the statistical power,
the six-month follow-up data was used for this purpose
(n = 980). Partial F were used to assess differences in
diagnoses groups regarding HRQoL. GLM was also used
to assess changes in HRQoL over time within groups. In
analyses, comparing HRQoL over time, only survivors
w i t ha n s w e r sa tt h ef o l l o wu pi n v o l v e di nt h ec o m p a r i -
s o nw e r eu s e d( n=4 7 8 ) .F u r t h e r ,w h e nI C Us u r v i v o r s
were compared with the reference group, survivors
older than 75 years were excluded because the reference
population did not include subjects older than 75 years.
This comparison was performed on the six-months data
(n = 780) in relation to the follow-up data with the
responders in all four occasions (n = 388). No adjust-
ments for multiple testing were performed in this study
and P values were regarded as descriptive. Findings were
considered significant; however, only if there were con-
current changes in several related variables. A P value
lower than 0.05, were considered as an indication of a
statistically important finding.
The Statistical Package for the Social Sciences (version
15.0; SPSS Inc., Chicago, IL, USA) was used for the sta-
tistical analyses.
Results
Study population
A total of 1,663 patients met the inclusion criteria. After
two remainders, 980 patients (59%) answered the ques-
tionnaire at six months. Of these 739 (75%) also
answered at 12 months, 595 (61%) at 24 months and
478 (47%) at 36 months (Figure 1). During the study
period 123 (12%) patients died and 379 (39%) patients
were lost to follow up (Figure 1).
The group who did not respond at all in the study
(n = 683) differed from the group who responded in
that there were fewer men (P =0 . 0 2 ) ,h i g h e ra v e r a g e
APACHE II score (P = 0.04), shorter LoS in the ICU
(P < 0.0001), shorter time on ventilator (P < 0.0001),
and fewer gastrointestinal admission diagnoses
(P = 0.02; Table 1).
The clinical characteristics of patients in the final
study population (e.g., the patients who answered at the
6-, 12-, 24- and 36-months follow ups) and the patients
who participated at some time but did not complete the
whole study is shown in Table 1. There were no signifi-
cant differences in sex, age, APACHE II score, LoS in
the ICU and in hospital, time treated on a ventilator, or
diagnosis at admission among the two groups of
patients. For the patients who answered at six months,
724 (74%) had pre-existing disease.
For the reference group, questionnaires were initially
sent out to 10,000 people. After two reminders, 6,093
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Page 3 of 10Patients admitted to the ICU 
During the study period 
(n=5306) 
Excluded n=2720 
   < 18 years (n=537) 
   < 24 hours (n=2183) 
Patients assessed for 
eligibility (n=2586) 
Excluded n=923 
   Deceased in the ICU (n=265) 
   Deceased in the hospital (n=367) 
   Deceased after discharge <6 months (n=150) 
   Readmitted patients to ICU (n= 141) 
Alive 6 months after 
discharge (n=1663) 
Lost to follow up n=683 
   Refused or to ill (n= 409) 
   No answer (n=247) 
   Unknown address (n=27) 
Participate at 6 month 
(n=980) 
Age 18-74 (n=780) 
Age 75 or over (n=200) 
Participate at 12 month 
(n=739) 
Participate at 24 month 
(n=595) 
Participate at 36 month 
(n=478) 
Age 18-74 (n=586) 
Age 75 or over (n=153) 
Age 18-74 (n=475) 
Age 75 or over (n=120) 
Age 18-74 (n=388) 
Age 75 or over (n=90) 
Deceased (n= 31) 
Refused (n=210) 
Deceased (n= 55) 
Refused (n=89) 
Deceased (n=37)  
Refused (n=80) 
Figure 1 Outline of the study protocol.
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Page 4 of 10(61%) had responded [8]. Apart from lower percentages of
immigrants and single households, the responders in the
reference group differed only marginally from the refer-
ence population of the county [8]. The reference group
were younger (P < 0.001), had a higher rate of women
(P < 0.001), higher rate of employment (P < 0.001), and
had a lower rate of comorbidity (51%; P < 0.001) than the
ICU group (n = 980; data not shown).
Determinants of HRQoL
The general linear model was used to evaluate the effect
of baseline variables (age, sex, sick leave before ICU,
marital status, employment before ICU, employment at
the follow-up time, education, born in Sweden, and pre-
existing disease) and ICU-related factors on HRQoL
based on the six months measure (APACHE II, LoS
ICU, LoS hospital, diagnosis on admission to ICU, time
on ventilator). In these analyses APACHE II score and
duration of stay in ICU, and time on ventilator showed
no association with HRQoL, whereas pre-existing dis-
ease, diagnosis at admission (trauma), duration of stay
in hospital, born in Sweden, sick leave before ICU,
employment before ICU (not employed), sex (female)
and age did [see Additional file 1].
Health-related quality of life over time
EQ-5D
Mean and median EQ-5D scores for the reference group
and ICU survivors (<75 years) who answered the ques-
tionnaire at all four occasions (n = 388) are shown in
Table 1 Clinical details
Answered on all four
occasions
Withdrawals between
6 and 36 months
Answered on
6 months
Non-
responders
Alive 6 months after
discharge
Variable (n = 478) (n = 502) P a (n = 980) (n = 683) P b (n = 1663)
Male/female 274/204 (57) 292/210 (58) 0.32 567/413 (58) 357/326
(52)
0.02 924/739 (55.6)
Age (years) 58.8 (17.0) 57.6 (19.3) 0.30 58.2 (18.2) 57.7 (19.6) 0.54 58.0 (18.8)
APACHE II score 15.3 (7.2) 15.9 (8.1) 0.22 15.6 (7.7) 16.3 (7.6) 0.04 15.9 (7.6)
Stay in ICU (hours) 126.6 (173.9) 119.7 (161.9) 0.52 123.1 (167.8) 93.1 (105.5) <0.001 110.9 (146.3)
Stay in hospital
(days)
15.5 (20.1) 14.6 (19.2) 0.46 15.0 (19.6) 14.8 (19.9) 0.85 14.9 (19.9)
Time on ventilator
(hours
68.1 (165.5) 56.2 (142.4) 0.23 62.0 (154.2) 33.5 (81.6) <0.001 50.2 (130.0)
Diagnosis on
admission to ICU
0.80 0.02
Multiple trauma 57 (12) 57 (11) 117 (12) 69 (10) 186 (11)
Sepsis 37 (8) 47 (9) 82 (8) 53 (8) 135 (8)
Gastrointestinal
disease
101 (21) 100 (20) 204 (21) 104 (15) 308 (18)
Respiratory
disease
85 (18) 112 (22) 196 (20) 147 (22) 343 (21)
Miscellaneous 198 (41) 186 (37) 381 (39) 309 (45) 690 (42)
Pre-existing diseases 725 (74)
Cancer 116 (16)
Diabetes 131 (13)
Cardiovascular 203 (28)
Gastrointestinal 122 (17)
Miscellaneous 628 (64)
Number of diseases
0 256 (26.1)
1 418 (42.7)
2 190 (19.4)
≥ 3 116 (11.8)
a, between groups answered at all occasions and withdrawals between 6 and 36 months; b, between groups answered at 6 months and non-responders
APACHE II: Acute Physiology and Chronic health Evaluation.
Data are number (%) or mean (standard deviation)
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Page 5 of 10Table 2. There were statistically significant differences
between them, and the difference was in the range of
0.15 to 0.18. No increases over time in the EQ-5D
values were seen for the ICU survivors.
The significant differences remained, although smaller,
when comparisons were made between those in both
groups (ICU and reference) that either had pre-existing
diseases or had been previously healthy (Table 2). The
overall mean difference in EQ-5D was 0.16 with and
without pre-existing disease at all four occasions, in the
group with pre-existing disease it was 0.14 and in the
previously healthy group it was 0.10. Regarding compar-
ison in the ICU patients only the difference in EQ-5D
was 0.21 between the group with pre-existing disease
and the previously healthy group. Patients in the pre-
viously healthy group had higher scores at all times than
the patients with pre-existing diseases (P < 0.0001).
Again no increases in EQ-5D were seen over time for
these two groups.
SF-36
For the ICU survivors (n = 388) improvement over time
was minor (Table 3). There were no statistically signifi-
cant changes in any SF-36 dimensions mean-score apart
from physical function between 6 and 24 months with
improvements from 66.3 to 70.1 (P = 0.002), physical
role functioning between 6 and 12 month with improve-
ments from 47.8 to 56.5 (P < 0.001), and social function
between 6 and 12 months with improvements from 73.0
to 76.9 (P = 0.008).
The reference group scored significantly higher
HRQoL than the study group in all dimensions of the
SF-36 (P < 0.001), with mean score differences between
6.9 (mental health) to 34.8 (physical role functioning) at
the six-month measure.
In Figure 2, the study group and reference group are
divided into the previously healthy and those having
pre-existing diseases (the measure at 6 and 36 months
are shown). The patients who were healthy before the
ICU period (n = 120) and the healthy reference group
(n = 2998) were significantly different (P < 0.005) in all
eight dimensions at all times apart from mental health
at six months (P = 0.2). The mean differences in SF-36
scale scores were in the range between 6.1 (mental
health) to 27.3 (role physical), in the group with pre-
existing disease it was from 3.7 (mental health) to 27.5
(role physical) and in the previously healthy group it
was from 4.3 (mental health) to 15.1 (role physical).
When the ICU patients with pre-existing disease
(n = 268) were compared with the reference group who
had diseases (n = 3,095) statistically significant differ-
ences (P < 0.04) were seen in all eight dimensions over
time apart from mental health at 12 months (P =0 . 0 7 ;
not shown in Figure). Figure 2 also shows that those in
the reference group with diseases had reduced HRQoL
in six of eight dimensions in SF-36 (not physical func-
tioning and role physical) compared with the study
group who were healthy before the intensive care
period.
HRQoL among patients dying during the follow up
In total, 139 patients who were included in the study
died during the follow up. They answered the HRQoL
enquiry at 6 and 12 months, or at 24 months after
Table 2 Health-related quality of life (EQ-5D) ICU patients aged younger than 75 years, answered at 6, 12, 24, and
36 months after discharge (n = 388) and reference group (n = 6093) data
ICU group (months)
Reference group 6 12 24 36 P value
EQ-5D
Number 6093 388 388 388 388
Mean 0.84 0.66 0.68 0.68 0.69 <0.001 †
95% CI 0.83 to 0.84 0.63 to 0.69 0.65 to 0.71 0.65 to 0.71 0.65 to 0.72
Median 0.85 0.72 0.73 0.73 0.73 <0.001 ‡
Pre-existing disease
Number (%) 3095 (51) 268 (69) 268 (69) 268 (69) 268 (69)
Mean 0.75 0.59 0.62 0.61 0.62 <0.001†
95% CI 0.7 to 0.76 0.55 to 0.63 0.58 to 0.65 0.57 to 0.65 0.58 to 0.66
Median 0.80 0.69 0.72 0.72 0.72 <0.001 ‡
Healthy
Number (%) 2998 (49) 120 (31) 120 (31) 120 (31) 120 (31)
Mean 0.92 0.81 0.83 0.84 0.82 <0.001 †
95% CI 0.92 to 0.93 0.77 to 0.85 0.79 to 0.87 0.80 to 0.88 0.79 to 0.86
Median 1.0 0.80 0.85 0.85 0.82 <0.001 ‡
Study group compared with reference group; † P value for mean (T-Test), ‡ P value for median (Wilcoxon).
CI: confidence interval; EQ-5D: EuroQol 5-Dimensions questionnaire.
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Page 6 of 10discharge from the hospital. These patients, with the
highest frequency of pre-existing diseases, had the low-
est HRQoL scores registered in the study (data not
shown).
Discussion
Data from this study shows the large impact of pre-
existing disease on HRQoL and the importance of
accounting for pre-existing disease when the HRQoL of
ICU survivors is studied. Four important and novel
observations were noted in this study:
First, pre-existing disease seems to be the most impor-
tant factor overall for long-term HRQoL after a critical
illness and a period of critical care. In this study the
only factor that affected all dimensions in the HRQoL
outcome was pre-existing disease (EQ-5D and all eight
dimensions in SF-36). Furthermore, the size of this
effect was most often in the range of 15 to 20 scale
units (SF-36). This is to be compared with the other fac-
tors examined where such large effects were not at all
registered. It is important to stress that a clinically sig-
nificant effect is claimed for a change larger than five
scale units [17]. To our knowledge, this is the first time
the effect of pre-existing disease has been addressed in a
systematic way in ICU-related outcome research.
Although claimed to be an important factor in other
Table 3 Health-related quality of life for the ICU patients aged younger than 75 years, answered at 6, 12, 24 and
36 months after discharge (n = 388) and reference group (n = 6093)
ICU patients ICU patients ICU patients ICU patients
Reference group 6 months 12 months 24 months 36 months P value
SF-36 (n = 6093) (n = 388) (n = 388) (n = 388) (n = 388)
PF Mean 87.86 66.29 68.20 70.07 68.76 <0.001 †
SD 19.29 29.15 29.53 28.41 28.90
CI (95%) 87.38:88.35 63.35:69.22 65.24:71.16 67.23:72.91 65.88:71.65
Median 95.0 75.0 75.0 75.0 75.0 <0.001 ‡
RP Mean 82.63 47.78 56.51 57.77 59.21 <0.001 †
SD 33.06 44.48 43.95 42.92 43.07
CI (95%) 81.79:83.48 43.29:52.27 52.08:60.95 53.46:62.07 54.87:63.55
Median 100 50.0 75.0 75.0 75.0 <0.001 ‡
BP Mean 73.70 62.34 63.93 64.38 63.98 <0.001 †
SD 25.47 29.68 29.12 29.15 30.07
CI (95%) 73.06:74.34 59.35:65.33 61.01:66.86 61.47:67.30 60.98:66.98
Median 84.0 62.0 62.0 62.0 62.0 <0.001 ‡
GH Mean 73.10 57.75 59.83 58.38 58.41 <0.001 †
SD 21.52 24.01 25.17 25.91 25.60
CI (95%) 72.55:73.65 55.33:60.18 57.30:62.36 55.78:60.98 55.86:60.97
Median 77.0 57.0 62.0 57.0 57.0 <0.001 ‡
VT Mean 65.75 56.18 58.43 57.08 56.64 <0.001 †
SD 22.52 24.62 23.94 23.96 24.46
CI (95%) 65.18:66.32 53.70:58.65 56.03:60.84 54.68:59.48 54.20:59.08
Median 70.0 55.0 60.0 60.0 55.0 <0.001 ‡
SF Mean 86.68 73.00 76.92 76.62 75.39 <0.001 †
SD 21.03 26.94 25.36 26.12 26.04
CI (95%) 86.15:87.21 70.29:75.71 74.38:79.47 74.00:79.23 72.79:77.99
Median 100 75.0 87.5 87.5 81.2 <0.001 ‡
RE Mean 85.36 68.01 69.76 69.38 71.71 <0.001 †
SD 30.25 41.55 40.74 40.98 39.99
CI (95%) 84.58:86.13 63.77:72.25 65.64:73.89 65.25:73.51 67.68:75.74
Median 100 100 100 100 100 <0.001 ‡
MH Mean 78.82 71.88 73.79 72.88 72.19 <0.001 †
SD 18.69 21.93 20.59 21.76 21.09
CI (95%) 78.35:79.30 69.67:74.08 71.72:75.85 70.70:75.06 70.08:74.29
Median 84.0 76.0 80.0 80.0 76.0 <0.001 ‡
Study group compared with reference group; † P value for mean (T-Test), ‡ P value for median (Wilcoxon)
BP, bodily pain; CI, confidence interval; GH, general health; MH, mental health; PF, physical functioning; RE, role limitations due to emotional problems; RP, role
limitations due to physical problems; SD, standard deviation; SF, social functioning; SF-36, short form health outcome; VT, vitality.
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adjusted for [2,18,19]. When we exclude the factor ‘pre-
existing diseases’ from the analyses, an increasing num-
ber of significant results were found for the ICU-related
variables as has been presented by others [3,20-23] (data
not shown).
Secondly, there were only few and minor improve-
ments over time in HRQoL assessed by EQ-5D and SF-
36. Data from SF-36, showed only clinically significant
(>5%) [17] improvements in role limitations due to phy-
sical problems. In our study we found no effects on
HRQoL by ICU-related factors. This finding supports
the lack of long-term improvement related to the speci-
fics of the critical care event. Furthermore, the minor
improvement, albeit not clinically relevant, that was
noted continued up to two years after the period in the
ICU, which is longer than the six months claimed by
others [1], but in line with Cuthbertson and colleagues
in their five-year follow-up study [24]. It needs then to
be stressed that, Dowdy and colleagues [2], in 2005,
pointed out that median follow-up time after critical ill-
ness in the studies they reviewed was only six months.
Since then, we have found only one study in general
ICU patients with a longer follow-up period after critical
illness than 12 months [24]. Several investigations exam-
ining HRQoL changes over time for intensive care
patients include all patients responding at each occasion.
This introduces a possible error in that it may falsely
improve HRQoL outcome over time. Such an improve-
ment is due to the loss of those dying early during the
follow-up period (being more ill, having a higher rate of
pre-existing diseases and with a lower HRQoL) leaving
t h ep a t i e n t sw i t hab e t t e rH R Q o L .T h i se f f e c tw a sa l s o
found in our data although the subgroups were small
(Figure 1).
Thirdly, and in line with our pre-study hypothesis, our
data support that the effects of ICU-related factors
(APACHE II score, admission diagnosis, time on ventila-
tor, duration of stay in ICU and hospital) are minor.
Results from other studies, however, indicate that
various ICU-related factors affect HRQoL after intensive
care measured by EQ-5D or SF-36. Kleinpell [20] and
Vedio and colleagues [25] found significant associations
between APACHE II score and poor physical function
or general health. For admission diagnosis, few studies
report differences between medical and surgical
diagnosis but patients who survive trauma injuries had
significantly worse pain or discomfort ratings on EQ-5D
than did other survivors after ICU care up to 18 months
after discharge [3,4,21]. We also recorded significant
influence by trauma on bodily pain. Previous studies
have found that time spent on the ventilator [26] or LoS
in the ICU [22,26] or the hospital [7] reduced HRQoL
by up to 12 months after critical illness. None of the
studies cited above included pre-existing diseases in
their analysis.
L a s t l y ,i tm a yb es t r e s s e dt h a tt h i ss t u d yb a s e do n
HRQoL data gathered by two different, separate and
validated HRQoL instruments, EQ-5D and SF-36, show
similar HRQoL outcome profiles. Furthermore, the
Figure 2 Medical Outcome Short Form results. Results from the eight scales in the reference group with diseases (n = 3095) and the healthy
group (n = 2998), compared with the ICU group aged 18 to 74 years at the 6 and 36 month measures, either with diseases (n = 268) or with
no disease (n = 120) who answered at all occasions (n = 388).
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the study group (n = 980) and has in addition a rela-
tively long follow-up time (36 months). In these three
aspects it is probably the most sizeable study for this
group of general ICU patients seen yet, which supports
the value of the findings.
When we aim to adjust for pre-existing diseases it is
important to find relevant control groups. Most often
those adjusted for age and sex are used [22,23,25].
However, they may not be adequate from the perspec-
tive of pre-existing disease, because the prevalence of
pre-existing disease is significantly higher among
patients in ICU [3,5,7,23], and pre-existing disease
reduces HRQoL [3-5,7,27]. Using healthy reference
groups adjusted only for age and sex then leads to a
faulty interpretation of the HRQoL values among for-
mer ICU patients as their HRQoL may be assumed to
be lower prior to the admittance to the ICU due to
their pre-existing diseases. Such comparisons are, how-
ever, seen in most studies [7,18,22-25]. The present
study was therefore constructed so that we used a large
reference population selected from the uptake area of
the hospitals and particularly adjusted for comorbidity.
This was practically feasible as the Division of Preven-
tive and Social Medicine and Public Health Science in
parallel made a general health survey in the county
(1 million inhabitants), which assessed comorbidity and
their effects on HRQoL in a large group encompassing
10,000 people [8].
The present study does not take into account the ser-
iousness of pre-existing diseases and the burden of each
disease [28]. We think that part of the differences that
remained after the adjustment for pre-existing diseases
is the result of such an effect. This needs to be
addressed more thoroughly in future studies. One inter-
esting finding is that the previously healthy persons that
were cared for in an ICU ended up with a HRQoL after
ICU stay that is almost identical to the group in the
reference population that has comorbidity. Assuming
that the event at the ICU has lead to the patient obtain-
ing a disease or impairment that has a chronic profile
almost all of the ICU-related HRQoL decrease for this
group may thus be explained. Therefore, special interest
for future HRQoL investigations needs to focus on the
specific diagnoses or effects that affect the patient dur-
ing the ICU treatment period.
Conclusions
This study, based on the comparison of HRQoL data
obtained from a sizeable, multicentre, long-term follow
up of ICU survivors and a large cohort of inhabitants
living in the uptake areas of the hospitals, confirms that
pre-existing disease have a larger impact on HRQoL
than ICU or psychosocial factors. Furthermore, the data
show that ICU survivors do not experience any signifi-
cant increase in their HRQoL after six months and only
minor improvement are registered up to 36 months
after discharge from ICU and hospital. These findings
underline the importance of accounting for pre-existing
diseases when HRQoL is studied in former ICU
patients.
Key messages
￿ The most important factor for the low HRQoL sta-
tus reported long term by former ICU patients was
their pre-existing diseases
￿ ICU-related factors had little effect on the reported
HRQoL
￿ Only minor improvements in HRQoL over time,
up to 36 months post ICU was seen
Additional file 1: Multivariate regression analysis (general linear
model (GLM)) mean score. Word file containing multivariate regression
analysis (GLM) mean score with significant variables from the univariate
analysis and Health-Related Quality of Life (HRQoL) at six months (n =
980).
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